116 related articles for article (PubMed ID: 8468556)
1. Mutational analysis of Moloney murine leukaemia virus surface protein gp70.
Skov H; Andersen KB
J Gen Virol; 1993 Apr; 74 ( Pt 4)():707-14. PubMed ID: 8468556
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the putative receptor-binding domain of Moloney murine leukemia virus glycoprotein gp70.
Panda BR; Kingsman SM; Kingsman AJ
Virology; 2000 Jul; 273(1):90-100. PubMed ID: 10891411
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein.
Thomas A; Gray KD; Roth MJ
Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129
[TBL] [Abstract][Full Text] [Related]
4. Functional dissection of the Moloney murine leukemia virus envelope protein gp70.
Bae Y; Kingsman SM; Kingsman AJ
J Virol; 1997 Mar; 71(3):2092-9. PubMed ID: 9032341
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance.
Granowitz C; Colicelli J; Goff SP
Virology; 1991 Aug; 183(2):545-54. PubMed ID: 1853560
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus.
Felkner RH; Roth MJ
J Virol; 1992 Jul; 66(7):4258-64. PubMed ID: 1318404
[TBL] [Abstract][Full Text] [Related]
7. The "putative" leucine zipper region of murine leukemia virus transmembrane protein (P15e) is essential for viral infectivity.
Ramsdale EE; Kingsman SM; Kingsman AJ
Virology; 1996 Jun; 220(1):100-8. PubMed ID: 8659102
[TBL] [Abstract][Full Text] [Related]
8. Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: rapid reversion during replication.
Granowitz C; Berkowitz RD; Goff SP
Virus Res; 1996 Mar; 41(1):25-42. PubMed ID: 8725100
[TBL] [Abstract][Full Text] [Related]
9. Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance.
Berkowitz RD; Goff SP
Virology; 1993 Oct; 196(2):748-57. PubMed ID: 8372445
[TBL] [Abstract][Full Text] [Related]
10. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
[TBL] [Abstract][Full Text] [Related]
11. Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity.
Housset V; De Rocquigny H; Roques BP; Darlix JL
J Virol; 1993 May; 67(5):2537-45. PubMed ID: 8474159
[TBL] [Abstract][Full Text] [Related]
12. A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.
Zavorotinskaya T; Albritton LM
J Virol; 1999 Dec; 73(12):10164-72. PubMed ID: 10559332
[TBL] [Abstract][Full Text] [Related]
13. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.
Hall FL; Gordon EM; Wu L; Zhu NL; Skotzko MJ; Starnes VA; Anderson WF
Hum Gene Ther; 1997 Dec; 8(18):2183-92. PubMed ID: 9449372
[TBL] [Abstract][Full Text] [Related]
14. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
Zavorotinskaya T; Albritton LM
J Virol; 1999 Jul; 73(7):5621-9. PubMed ID: 10364311
[TBL] [Abstract][Full Text] [Related]
15. Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes.
Lebedeva I; Fujita K; Nihrane A; Silver J
J Virol; 1997 Sep; 71(9):7061-7. PubMed ID: 9261436
[TBL] [Abstract][Full Text] [Related]
16. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between monomers of the retroviral envelope protein complex.
Zhao Y; Lee S; Anderson WF
J Virol; 1997 Sep; 71(9):6967-72. PubMed ID: 9261425
[TBL] [Abstract][Full Text] [Related]
18. Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro.
Nihrane A; Fujita K; Willey R; Lyu MS; Silver J
J Virol; 1996 Mar; 70(3):1882-9. PubMed ID: 8627713
[TBL] [Abstract][Full Text] [Related]
19. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
20. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.
O'Reilly L; Roth MJ
J Virol; 2000 Jan; 74(2):899-913. PubMed ID: 10623753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
